Differences

This shows you the differences between two versions of the page.

--- path [2023/04/10 09:12]
liam removed
+++ — (current)
@@ Line 1: / Line 1: @@
-====== PATH ======
-{{ ::440px-path_logo_color.png?150|}}
-**PATH** (Program for Appropriate Technology in Health) is an international non-governmental [[public health]] organization based in Seattle, Washington. It was started with a grant from the [[Ford Foundation]].((//Global Partners.// PATH. Retrieved April 8, 2022, from https://archive.ph/jA9z5))
-===== Affiliations =====
-==== Partners ====
-PATH is partnered with the [[Bill & Melinda Gates Foundation]], the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies;Johnson & Johnson]], [[Microsoft]], [[MSR Global Health]], [[pharmaceutical_companies:Novo Nordisk]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Serum Institute of India]], the [[Siemens Foundation]], the [[Tableau Foundation]] (a [[Salesforce]] affiliate), [[UNICEF]], [[Wipro]], and the [[World Health Organization]].((//Corporate Partnerships & Donations.// PATH. Retrieved April 8, 2022, from https://archive.ph/spp0I))
-===== Work =====
-==== Vaccines ====
-The PATH Center for Vaccine Innovation and Access (CVIA) works to accelerate the development and introduction of [[vaccines]] around the world, in partnership with [[Gavi|Gavi, the Vaccine Alliance]], [[UNICEF]] and the [[World Health Organization]].((//Developing and delivering lifesaving vaccines.// PATH. Retrieved April 8, 2022, from https://archive.ph/TNzT0))
-=== Typhoid ===
-In 2018, the WHO endorsed a [[typhoid]] vaccine. PATH worked alongside their partners at the [[Typhoid Vaccine Acceleration Consortium]] (TyVAC) to expedite funding and delivery of the vaccine to millions of children in [[Pakistan]], culminating in a mass-vaccination program in 2019.((Latimer, A. (2019, December 2). //In Pakistan, protecting 9 million kids from typhoid is just the start.// PATH. https://archive.ph/Efkqz))
-=== Meningitis ===
-In 2010, PATH delivered [[pharmaceutical_products:MenAfriVac]], a [[meningitis]] vaccine, to more than 10 million people in Burkina Faso, [[Africa]]. The product was developed with the [[pharmaceutical_companies:Serum Institute of India]] and the WHO.((//Lining up for hope—and a meningitis vaccine.// (2018, June 15). PATH. https://archive.ph/PBan8))
-=== COVID-19 ===
-PATH has focused primarily on "[[vaccine equity]]" and "access" to [[COVID-19 vaccines]], helping launch [[COVAX]]. According to their website, their work "spans the full vaccine development to delivery spectrum, including supporting country vaccine readiness; COVAX and other efforts to ensure equitable access to vaccine; vaccine development and manufacturing scale-up; vaccine clinical evaluation; immunization system resiliency; and other efforts."((Center for Vaccine Innovation and Access. //PATH strives for vaccine equity in response to COVID-19.// PATH. Retrieved April 8, 2022, from https://archive.ph/0BtaG))
-PATH assisted in preparation of Phase III clinical trial sites for [[COVID-19 vaccines]] with funding from the BMGF and CEPI.((COVID-19 Site Readiness Project team. (2021, May 10). //Facilitating real-world research on COVID-19 vaccines.// PATH. https://archive.ph/lL9ir))